一个发展中国家实现高值救命药全民可及的成功经验及对我国的启示
x
请在关注微信后,向客服人员索取文件
篇名: | 一个发展中国家实现高值救命药全民可及的成功经验及对我国的启示 |
TITLE: | |
摘要: | 目的:为我国促进高值救命药全民可及提出政策建议。方法:通过查阅文献和对知情人士访谈回顾分析泰国的医疗保障体系、基本药物制度、医疗服务和药品采购供应体系、抗艾滋病药可及性策略、药品准入机制、高值救命药全民可及促进策略及对我国的启示。结果与结论:泰国响应国际社会将治疗重大疾病、疗效确定、且临床无可替代的高值专利药纳入基本药物的理念,制定了国家基本药物目录高值药特殊目录和定期更新机制,建立了可持续的筹资和保障供应体系,以卫生技术评估服务于药物政策,充分利用国际公约赋予发展中国家的合法权益,以国内配套法律为依据,通过国家谈判和政府各部门间及与非政府部门的携手努力,获得了可负担的价格。上述经验对我国实现高值救命药全民可及提供了一定借鉴。 |
ABSTRACT: | OBJECTIVE: To provide suggestions for promoting universal access to expensive life-saving medicines for China. METHODS: Literature review and key informant interview were used to conduct restrospective analysis of the medical insurance system, essential medicines system, medical services delivery system and drugs’ procurement and supply strategies to promote access to anti-HIV medicines universal access to expensive life-saving medicines in Thailand and its implications to China. RESULTS & CONCLUSIONS: Thailand responded to the call of international societies in including non-substitutable patented expensive life-saving medicines with confirmed efficacy as a special category of essential medicines, developed special directory and regular update mechanism for expensive medicines in national essential medicines, established sustainable financing and supply systems and health technology assessment to serve policy setting, fully used the rights of developing countries endorsed by the international conventions and national laws, obtained affordable prices through national negotiations and coordination among governmental agencies and with non-governmental organizations. Thai’s experience provide valuable reference for China to achieve universal access to expensive life-saving medicines in a developing country. |
期刊: | 2017年第28卷第3期 |
作者: | 孙静,蒋锋,赵琪,刘远立 |
AUTHORS: | SUN Jing,JIANG Feng,ZHAO Qi,LIU Yuanli |
关键字: | 高值救命药;全民可及;泰国;基本药物;经验 |
KEYWORDS: | Expensive life-saving medicines; Universal access; Thailand; Essential medicines; Experiences |
阅读数: | 525 次 |
本月下载数: | 21 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!